Peptide Synthesis: Global Markets

Report Code: BIO252A

Publish Date: May 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Report Includes

  • 63 data tables and 56 additional tables
  • An overview of the global market for peptide synthesis
  • Analyses of global market trends, with market revenue data from 2020 to 2022, estimates for 2023, and projected CAGRs through 2028
  • Estimates of the market size and revenue forecast, and a market share analysis by product type, synthesis area, application, end-user and region
  • Facts and figures pertaining to major market dynamics, technological trends, developments in peptide production, and pipeline drugs (manufactured using peptides)
  • Discussion of sustainability trends and factors, including consumer attitudes, companies’ ESG rankings, case studies and the ESG practices of companies
  • Analysis of the industry structure, including company market shares, recent M&A activity and venture funding
  • Competitive intelligence on the leading companies’ products, business strategies, financials and revenues
  • Profiles of the leading companies, including Novo Nordisk A/S., AbbVie Inc., Lilly, Novartis AG, AstraZeneca and Teva Pharmaceutical

Report Scope

The report provides a detailed summary of the peptide synthesis market, with a focus on peptide therapeutics; a competitive landscape; and company profiles that include revenue, product portfolio and news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period.

The report will enable key players, other strategists and start-ups to make informed decisions about the production, marketing and licensing of goods and services. Organizations, exporters and distributors should find the information about market development and trends useful. The segments of the market provided in the report are peptide type, applications and synthesis type. Regional market analysis is provided for all segments, and country-level analysis in some cases. Key developments and ESG information for the companies is provided based on the market.

The market is divided into segments and by application/industry as follows:

By peptide types:

  • Synthetic peptides.
  • Antimicrobial peptides.
  • Hormonal peptides.
  • Bioactive peptides.
  • Collagen peptides.
  • Others.

By application:

  • Cancer.
  • Diabetes.
  • Neurology.
  • Others (cardiology, rare diseases, etc.).
  • Peptide therapeutics.
  • Cosmetics.
  • Nutraceuticals.
  • Others (drug discovery, medical imaging).

By synthesis type:

  • Solid-phase.
  • Solution-phase.
  • Hybrid-phase.

For each of these areas, current products in the market are identified, measuring the market size and identifying potential market drivers. Forecasts for 2028 are attained by analyzing the current competitors’ market shares for the base year of 2022. A top-down approach was also followed to determine peptide synthesis market shares in 2022 by consulting secondary and primary sources.

By geographic region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World. The markets in countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries are analyzed. For market estimates, data is provided for 2022 as the base year, with estimates for 2023 and forecast values for 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $83.7 billion
Market size forecast $157.5 billion
Growth rate CAGR of 11.8% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Type, Synthesis Type, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered U.S., Mexico, Canada, Germany, France, U.K., Spain, Italy, China, Japan, India, Australia, and New Zealand, GCC countries, Brazil
Key Market Drivers
  • Developments in peptide drug delivery.
  • Rising prevalence of chronic diseases.
  • Increase in biotech spending.
  • Increase in infectious and chronic diseases
Companies studied
ABBOTT ABBVIE INC.
AMGEN INC.ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH BRISTOL-MYERS SQUIBB CO.
B. BRAUN SE LILLY
MERCK & CO. INC.MODERNA INC.
NOVARTIS AGNOVO NORDISK A/S
SANOFITEVA PHARMACEUTICAL INDUSTRIES LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The market is projected to grow from $83.6 billion in 2022 to $157.5 billion in 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period.
The key factors driving the growth of the Global Peptide Synthesis Market: Focus on Peptide Therapeutics:
  • Rising Prevalence of Chronic Diseases
  • Increase in Biotech Spending
  • Development in Peptide Drug Delivery
  • Increase in Infectious and Chronic Diseases.
The Global Peptide Synthesis Market: Focus on Peptide Therapeutics is segmented based on
  • Application
  • Synthesis type
  • Peptides type.
By Application, peptide therapeutic segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Peptide Synthesis: Global Markets135Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview 4Free
Chapter- 3: Market Dynamics 12Free
Chapter- 4: Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing 3Free
Chapter- 5: Market Analysis, by Segment 49Free
Chapter- 6: Competitive Landscape5Free
Chapter- 7: Sustainability in the Peptide Synthesis Industry: An ESG Perspective 5Free
Chapter- 8: Appendix 53Free

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - Feb 2024 | Publisher - Partha Sarathi Das | Code - BIO079E

The global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.7% during the forecast period of 2023-2028.

Global Market for Anti-obesity Drugs

Published - Dec 2023 | Publisher - BCC Publishing | Code - PHM281A

This report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report details the anti-obesity drugs market based on drug type, distribution channel, and region.

Biosimilars: Global Markets

Published - Jun 2021 | Publisher - Kamna Jhamb | Code - BIO090D

The global biosimilars market should reach $60.1 billion by 2025 from $15.7 billion in 2020 at a compound annual growth rate (CAGR) of 30.9% for the forecast period of 2020 to 2025.

Recent Reports

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Published - Jun 2024 | Publisher - Gundreddy Gopinadh | Code - BIO157C

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Peptide Synthesis: Global Markets
Sample Report